|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Page 1 of 1
-
Three Game-Changers For Big Pharma
on May 15, 2008 by Michael Steinberg
-
Six Significant Gene Therapy Stocks
on May 13, 2008 by Stockerblog
-
Isis Pharmaceuticals Panic Overdone
on Apr 25, 2008 by Michael Steinberg
-
Rosetta Genomics: Mining Genes From Junk (Part II)
on Apr 14, 2008 by Ohad Hammer
-
Fast Money Recap, 4/1/08: Gold Takes the Elevator
on Apr 02, 2008 by SA Editor Miriam Metzinger
-
Isis-Genzyme: Deal of the Year?
on Jan 28, 2008 by Freund Investing
-
ISIS Pharma Should Jump on 'Multiple Catalysts'
on Jan 17, 2008 by Notable Calls
-
A Volatile January for Financials, Healthcare
on Jan 13, 2008 by Promod Radhakrishnan
-
Wal-Mart's Guidance Shows No Sign of Slow-Down, Good for Investors
on Jan 11, 2008 by Todd Sullivan
-
Pharma, Biotech Present Great Investment Opportunities in 2008
on Jan 09, 2008 by A. Reza Saadat
-
A Win-Win for Isis, Genzyme in Cholesterol Drug Deal
on Jan 09, 2008 by Brett Scott
-
Tuesday's Options Report: CFC, Starbucks, ISIS, CVS, BUD, DFS
on Jan 08, 2008 by Andrew Wilkinson
-
VMware, Isis Pharma: Avoid Emotion in Market Swings
on Jan 08, 2008 by David Gordon
-
A Bark Worse Than Its Bite
on Sep 26, 2007 by David Gordon
-
Gaming Rules For Trading Biotech Stocks
on Jul 11, 2007 by Mike Havrilla
-
Differentiating Between Stocks and the Stock Market
on Jun 08, 2007 by David Gordon
-
Companies With The Most Analyst Attention & Affection
on Jun 05, 2007 by Bespoke Investment Group
-
Biotech Day In Review: Regeneron Up On AMD Data
on Mar 28, 2007
-
Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
on Mar 27, 2007 by Centient Biotech Investor
-
Biotech Day In Review: Amgen Hit with SEC Investigation
on Mar 01, 2007 by Centient Biotech Investor
-
Biotech IPO Watch: Rosetta Genomics Using MicroRNAs for Diagnostics
on Mar 01, 2007 by Centient Biotech Investor
-
Eye on Alnylam: Silencing the Gene
on Feb 06, 2007 by Anthony Payne
-
Expecting a Big Move in Isis Pharma
on Jan 10, 2007 by David Gordon
-
Isis To Profit From Pfizer's Stumble
on Dec 05, 2006 by David Gordon
-
Biotech IPO: Highlights from Rosetta Genomics' F1 Filing
on Sep 10, 2006 by Evelyn Rubin
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »